Thomas C Lavoy - Net Worth and Insider Trading
Thomas C Lavoy Net Worth
The estimated net worth of Thomas C Lavoy is at least $418,505 dollars as of 2024-09-23. Thomas C Lavoy is the CEO and Chairman of the Board of Perspective Therapeutics Inc and owns about 31,633 shares of Perspective Therapeutics Inc (CATX) stock worth over $418,505. Thomas C Lavoy is also the Director of Alanco Technologies Inc and owns about 0 shares of Alanco Technologies Inc (ALAN) stock worth over $0. Details can be seen in Thomas C Lavoy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas C Lavoy has not made any transactions after 2018-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas C Lavoy
Thomas C Lavoy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas C Lavoy owns 2 companies in total, including Perspective Therapeutics Inc (CATX) , and Alanco Technologies Inc (ALAN) .
Click here to see the complete history of Thomas C Lavoy’s form 4 insider trades.
Insider Ownership Summary of Thomas C Lavoy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2018-03-01 | director |
| ALAN | Alanco Technologies Inc | 2014-11-05 | director |
Thomas C Lavoy Latest Holdings Summary
Thomas C Lavoy currently owns a total of 2 stocks. Among these stocks, Thomas C Lavoy owns 31,633 shares of Perspective Therapeutics Inc (CATX) as of March 1, 2018, with a value of $418,505 and a weighting of 100%. Thomas C Lavoy also owns 0 shares of Alanco Technologies Inc (ALAN) as of April 22, 2004, with a value of $0 and a weighting of 0%.
Latest Holdings of Thomas C Lavoy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2018-03-01 | 31,633 | 13.23 | 418,505 |
| ALAN | Alanco Technologies Inc | 2004-04-22 | 0 | 0.03 | 0 |
Holding Weightings of Thomas C Lavoy
Thomas C Lavoy Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas C Lavoy has made a total of 0 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 5,000 shares on March 1, 2018, which cost Thomas C Lavoy around $22,000.
According to the SEC Form 4 filings, Thomas C Lavoy has made a total of 0 transactions in Alanco Technologies Inc (ALAN) over the past 5 years. The most-recent trade in Alanco Technologies Inc is the sale of 1,000 shares on April 22, 2004, which brought Thomas C Lavoy around $35,200.
Insider Trading History of Thomas C Lavoy
- 1
Thomas C Lavoy Trading Performance
GuruFocus tracks the stock performance after each of Thomas C Lavoy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas C Lavoy is -4.42%. GuruFocus also compares Thomas C Lavoy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas C Lavoy within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas C Lavoy's insider trading performs compared to the benchmark.
Performance of Thomas C Lavoy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.19 | | | | | |
| Relative Return to S&P 500(%) | 3.61 | | | | | |
Thomas C Lavoy Ownership Network
Thomas C Lavoy Owned Company Details
What does Perspective Therapeutics Inc do?
Who are the key executives at Perspective Therapeutics Inc?
Thomas C Lavoy is the director of Perspective Therapeutics Inc. Other key executives at Perspective Therapeutics Inc include Chief Financial Officer Jonathan Robert Hunt , Vice President Lori A Woods , and director & CEO Johan M. Spoor .
Perspective Therapeutics Inc (CATX) Insider Trades Summary
Over the past 18 months, Thomas C Lavoy made no insider transaction in Perspective Therapeutics Inc (CATX). Other recent insider transactions involving Perspective Therapeutics Inc (CATX) include a net purchase of 427,455 shares made by Williamson Robert F Iii , a net purchase of 224,033 shares made by Lori A Woods , and a net purchase of 151,806 shares made by Jonathan Robert Hunt .
In summary, during the past 3 months, insiders sold 0 shares of Perspective Therapeutics Inc (CATX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Perspective Therapeutics Inc (CATX) were sold and 6,226,724 shares were bought by its insiders, resulting in a net purchase of 6,226,724 shares.
Perspective Therapeutics Inc (CATX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Perspective Therapeutics Inc Insider Transactions
Thomas C Lavoy Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas C Lavoy. You might contact Thomas C Lavoy via mailing address: C/o Isoray, Inc., 350 Hills Street, Ste 106, Richland Wa 99354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
